第一作者机构:[1]Sichuan Univ, Inst Hematol, Dept Hematol, West China Hosp, Chengdu, Peoples R China
推荐引用方式(GB/T 7714):
Tang Wenjiao,Li Yan,Liang Qiushi,et al.Phase I Study of a Novel Oral Proteasome Inhibitor TQB3602 in Relapsed/Refractory Multiple Myeloma[J].BLOOD.2022,140:4396-4397.doi:10.1182/blood-2022-168091.
APA:
Tang, Wenjiao,Li, Yan,Liang, Qiushi,Qu, Ying,Zhang, Li...&Niu, Ting.(2022).Phase I Study of a Novel Oral Proteasome Inhibitor TQB3602 in Relapsed/Refractory Multiple Myeloma.BLOOD,140,
MLA:
Tang, Wenjiao,et al."Phase I Study of a Novel Oral Proteasome Inhibitor TQB3602 in Relapsed/Refractory Multiple Myeloma".BLOOD 140.(2022):4396-4397